Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia

Acta Neuropathologica

Volumn 88, Issue 6, 1994, Pages 538-544

  Everall, Ian P ^a   Glass, Jonathan D ^b   McArthur, Justin ^b   Spargo, Edward ^a,b   Lantos, Peter ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; Human immunodeficiency virus neuronal loss; Stereology

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL DENSITY; CELL LOSS; CELL VOLUME; CLINICAL ARTICLE; DEMENTIA; DISEASE SEVERITY; FRONTAL LOBE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MORPHOMETRICS; NERVE CELL; PRIORITY JOURNAL; STEREOLOGY; TEMPORAL LOBE;

AIDS DEMENTIA COMPLEX; FRONTAL LOBE; HUMAN; NEURONS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE; ZIDOVUDINE;

EID: 0027985798     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/BF00296490     Document Type: Article

References (42)

1. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection
2. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive peptide
3. HIV-associated disease of the nervous system and proposal for neuropathology-based terminology
4. The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study
5. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists
6. Neuronal loss in the frontal cortex in HIV infection
7. Neuronal number and volume alterations in the neocortex in HIV-infected individuals
8. Glutamate, nitric oxide and cell-cell signalling in the nervous system
9. Clinical-neuropathologic correlation in HIV associated dementia
10. Subacute cerebellar syndrome as the first manifestation of AIDS dementia complex
11. Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain
12. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson
13. The nucleator
14. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
15. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status
16. HIV envelope protein-induced neuronal damage and retardation of behavioural development in rat neonates
17. Loss of neurons in the frontal cortex in AIDS brains
18. HIV-related neurotoxicity
19. Spectrum of human immunodeficiency virus-associated neocortical damage
20. Selective neuronal vulnerabiluty in HIV encephalitis
21. Cortical dendritic pathology in human immunodeficiency virus encephalitis
22. Dementia in AIDS patients
23. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1
24. The AIDS-dementia complex. I. Clinical features
25. The AIDS-dementia complex. II. Neuropathology
26. The AIDS dementia complex
27. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neutrochemical alterations in cultured human brains
28. Nigral degeneration in acquired immune deficiency syndrome (AIDS)
29. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex
30. HIV-1-associated cognitive/motor complex
31. Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial
32. The unbiased estimation of number and sizes of arbitrary particles using the disector
33. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells
34. Persistent human immunodeficiency virus type-1 infection in human fetal glial cells reactivated by T-cell factors or by cytokines tumor necrosis factor alpha and interleukin-1 beta
35. Cytokine expression in the brain during the acquired immunodeficiency syndrome
36. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study
37. Neocortocal damage during HIV infection
38. Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material
39. Response of human immunodeficiency virus associated neurological disease to 3‘-azido-3’-deoxythymidine